Business

Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

Financial Post · August 19, 2026 at 4:03 a.m.

VANCOUVER, British Columbia, Aug.

19, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce the results of voting at its 2026 annual general meeting of shareholders held on August 18, 2026, in Toronto, Ontario (the “Meeting”).

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

More from Financial Post

BlackRock® Canada Announces August Cash Distributions for the iShares® ETFs

Transaction in Own Shares

Clash Royale Searches for Its First-Ever Rage Emote, As New Research Finds 85% of Players Who Rage Quit Come Back Enjoying the Game More

NEWS RELEASE OMNI-LITE INDUSTRIES REPORTS SECOND QUARTER AND YEAR-TO-DATE FISCAL 2026 RESULTS

More in Business

BlackRock® Canada Announces August Cash Distributions for the iShares® ETFs

Transaction in Own Shares

Clash Royale Searches for Its First-Ever Rage Emote, As New Research Finds 85% of Players Who Rage Quit Come Back Enjoying the Game More

NEWS RELEASE OMNI-LITE INDUSTRIES REPORTS SECOND QUARTER AND YEAR-TO-DATE FISCAL 2026 RESULTS

China Foreign Trade Industry Annual Mega-Event “XTransfer Summit 26” Concludes Successfully

LEADING EDGE MATERIALS CLOSES FIRST TRANCHE OF C$ 6,000,000 PRIVATE PLACEMENT WITH BINDING STANDBY SUBSCRIPTION AND COMMITMENT OF CORNERSTONE SHAREHOLDER